Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Bayer Acquiring Therapeutic Peptides in $1.1B+ Deal

Bayer AG, the global drug maker and agricultural chemical company, is partnering with a Japanese biologics enterprise to discover a series of peptides for therapies. . . . → Read More: Bayer Acquiring Therapeutic Peptides in $1.1B+ Deal

Process Devised for Continuous Stem Cell Production

Researchers in the U.K. developed a process for closed-loop continuous production and collection of large quantities of stem cells for therapies. . . . → Read More: Process Devised for Continuous Stem Cell Production

New Drug Shown to Reduce Depressive Behaviors

A new type of treatment for depression that works differently from most other anti-depressive drugs was shown in lab mice to reduce depression-like behaviors. . . . → Read More: New Drug Shown to Reduce Depressive Behaviors

Start-Up Formed to Develop Non-Opioid Pain Drugs

A new enterprise is being formed to develop non-addictive drugs for chronic pain that use different biochemical processes than opioid pain relievers. . . . → Read More: Start-Up Formed to Develop Non-Opioid Pain Drugs

Artificial Beta Cells Shown to Produce Insulin as Needed

A biomedical engineering team developed artificial beta cells that in animal tests perform similar to natural cells in the pancreas to produce insulin as needed for controlling blood glucose levels. . . . → Read More: Artificial Beta Cells Shown to Produce Insulin as Needed

Novartis Acquires Nuclear Meds Developer in $3.9B Deal

Drug maker Novartis is purchasing a company that develops therapies and diagnostics using radio isotopes for neuroendocrine and other cancers. . . . → Read More: Novartis Acquires Nuclear Meds Developer in $3.9B Deal

Phone-Based Lupus Home Test Kit in Development

A home test kit using smartphone imaging is being created by biomedical engineers to detect kidney inflammation caused by lupus, an autoimmune disorder. . . . → Read More: Phone-Based Lupus Home Test Kit in Development

Online Game Harnessed to Combat Foodborne Toxins

A consortium of companies and university labs is recruiting participants in an online computer game to design synthetic proteins to neutralize a toxin that contaminates food crops. . . . → Read More: Online Game Harnessed to Combat Foodborne Toxins

Gas-Jet Printing Process Developed for Medications

A team of material scientists and biomedical engineers designed techniques for producing pharmaceuticals on demand by printing drugs as thin films. . . . → Read More: Gas-Jet Printing Process Developed for Medications

Drug Delivery Technology Licensed in $2B Deals

The biotechnology company Halozyme Therapeutics Inc. is licensing its technology for making infusion drugs deliverable with injections to two more drug makers. . . . → Read More: Drug Delivery Technology Licensed in $2B Deals